CRISPR Therapeutics to Present at the 2022 Bank of America Healthcare Conference
ZUG, Switzerland and CAMBRIDGE, Mass., May 04, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP),…
Month: May 2022
Rhythm Pharmaceuticals to Present at BofA Securities 2022 Healthcare Conference
BOSTON, May 04, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
Immutep Presents New and Significant Data from the AIPAC Study
Statistically significant increase in innate and adaptive immune response biomarkers (monocyte and CD8 T cell…
RAPT Therapeutics Expands Leadership Team with Multiple Key Hires
SOUTH SAN FRANCISCO, Calif., May 04, 2022 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT),…
Allena Pharmaceuticals Announces $2.8 Million Registered Direct Offering
NEWTON, Mass., May 04, 2022 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage,…
Aspargo Acquires Bandol® Sildenafil Spray, Currently Marketed In Spain
Immediate revenue and expansion of global footprint Acquisition transforms Aspargo into a revenue producing company…
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
PHILADELPHIA and OXFORDSHIRE, United Kingdom, May 04, 2022 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP),…
Achilles Therapeutics Appoints Bernhard Ehmer to Board of Directors
LONDON, May 04, 2022 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical…
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2022
Initiated EMERALD-1 phase 2a trial of MORF-057 in patients with ulcerative colitis Described new understanding…
AviadoBio to Present Pre-clinical Data on its Gene Therapy Candidate for Frontotemporal Dementia at ASGCT 2022
AviadoBio to Present Pre-clinical Data on its Gene Therapy Candidate for Frontotemporal Dementia at ASGCT…
Immunovant to Present at LifeSci Partners’ Immunology and Inflammation Symposium on May 10th
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical…
Synthetic Biologics Announces Presentation on VCN-11, a Novel Oncolytic Adenovirus Designed to Evade Neutralizing Antibodies at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
– VCN-11 incorporates a proprietary albumin binding domain in the virus shell with the potential…
Positive 18-Month Data from Ongoing Phase 1/2 Clinical Study of AGTC-501 Presented at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting
– Data reconfirm previously highlighted safety and efficacy potential of AGTC-501 as a treatment for…
Medolife Rx Schedules Conference Call with Investment Community to Discuss New Updates and Answer Questions
BURBANK, CA, May 04, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medolife Rx, Inc. (“Medolife”),…
Aadi Bioscience Announces Unique Permanent J-code Issued for FYARRO™ from Centers for Medicare and Medicaid Services
J-Code, Effective July 1st, Will Enable a Streamlined Reimbursement Process for FYARRO™ LOS ANGELES, May…
Vericel Reports First Quarter 2022 Financial Results
First Quarter Total Net Revenue of $36.1 Million Conference Call Today at 8:30am Eastern Time…
EyePoint Pharmaceuticals Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Developments
– Presented positive eight-month safety and efficacy data from ongoing DAVIO Phase 1 clinical trial…
Mindset Pharma to Participate in Upcoming Conferences in May 2022
TORONTO, May 04, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
Genenta Progresses to Higher Dosing Cohort in Temferon™ Phase 1/2a Clinical Trial in Glioblastoma Multiforme
No dose limiting toxicity observed in previous three dose level cohortsRepresents a 50% higher dose…
Aptose Receives Fast Track Designation for HM43239 in Relapsed/Refractory AML Patients and FLT3 Mutation
SAN DIEGO and TORONTO, May 04, 2022 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or…